Danish diabetes technology company Hedia has announced a significant leadership change, appointing Rasmus Kofoed as Chief Executive Officer (CEO) effective December 1, 2025. Kofoed takes over from Lars Christian Lund, who has decided to step down after approximately two years in the role to pursue a Group CEO position at another international firm.
Founded in 2016, Hedia has established itself as a frontrunner in digital diabetes management. The company develops innovative solutions that empower individuals with insulin-dependent diabetes to better understand and manage their treatment through the use of data, artificial intelligence, and user-friendly app technology.
Leadership Transition and Future Ambitions
Carl Bilbo, Chairman of the Board at Hedia, praised Lund’s leadership, noting that under his guidance, the company evolved from an ambitious start-up to a professional scale-up. Bilbo highlighted Lund’s crucial role in strengthening the organization, achieving Medical Device Regulation (MDR) approval, and laying the groundwork for global expansion.
He expressed gratitude for Lund’s contributions, stating, “On behalf of the board, I wish to thank him for his outstanding contribution and dedication.” Bilbo also welcomed Kofoed, emphasizing his strong strategic and commercial profile, which is backed by extensive experience in the life sciences and medtech sectors.
Kofoed’s career includes senior leadership roles at notable companies such as Novo Nordisk, Abbott, Roche, and Medtronic. He previously served as CEO of ChemoMetec, where he was responsible for commercial strategy and international growth. With this wealth of experience, Kofoed aims to enhance Hedia’s product offerings and market presence while expanding its international partnerships.
A Vision for Growth in Digital Diabetes Care
In his statement, Kofoed expressed enthusiasm for his new role, stating, “I see enormous potential in Hedia. The company combines clinical insight with technology in a way that creates real value for people with diabetes.” He looks forward to collaborating with the team to broaden their reach, solidify partnerships, and continue the journey towards making Hedia a leader in digital diabetes care.
The transition in leadership marks a pivotal moment for Hedia as it continues to build on its success and reaffirm its commitment to expanding its international footprint and commercial engagement. With Kofoed at the helm, the company is poised to navigate the next phase of its growth trajectory effectively.
For more information, visit Hedia’s official website at www.hedia.com.
